ACE2 serum concentrations are reported to be low in connective tissue diseases such as SLE, RA (rheumatoid arthritis), SjS (primary Sjögren's syndrome), and SSc (systemic sclerosis), while an elevated ACE2 level predicts the COVID-19 severity [14,15]. This evidence concerns the gene ACE2 and Schwartz-Jampel syndrome.